Dr. Steve Martinez
I've won the following awards
Top Breast Surgeon, Washington
Thought Leader, Sacramento, CA
Most Influential, Sacramento, CA
Most Influential Doctor, Everett Region
Top Surgical Oncologist, National
Top Doctor, Sacramento, CA
Top Doctor, Everett Region
Associate Professor of Surgery, UC Davis Comprehensive Cancer Center
Combined Analysis of Phase III Trials Evaluating [(99m)Tc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma.
Ann. Surg. Oncol., Oct (2012)
Utilization of Sentinel Lymph Node Biopsy in Patients with Ductal Carcinoma In Situ Undergoing Mastectomy.
Ann. Surg. Oncol., Sep (2012)
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma.
Anticancer Res., Sep;32(9):3911-5 (2012)
Treatment options for metaplastic breast cancer.
ISRN Oncol., 2012:706162 (2012)
Rural-urban disparities in use of post-lumpectomy radiation.
Med. Oncol., Dec;29(5):3250-7 (2012)
Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma.
J Surg Oncol., Dec;106(7):807-10 (2012)
P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy.
Hum. Pathol., Nov;43(11):1948-54 (2012)
Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy.
J. Surg. Res., Sep;177(1):e21-6 (2012)
Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer.
Med. Oncol., Sep;29(3):1523-8 (2012)
Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors.
Arch Dermatol., Sep;147(9):1058-62 (2011)
Predicting survival for well-differentiated liposarcoma: the importance of tumor location.
J. Surg. Res., Jun;175(1):12-7 (2012)
Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma.
Ann. Surg. Oncol., Feb;19(2):504-10 (2012)
Do radiation use disparities influence survival in patients with advanced breast cancer?
Cancer., Jan;118(1):196-204 (2012)
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention.
Ann. Surg., Aug;254(2):333-8 (2011)
Outcomes for lymph node-positive cutaneous melanoma over two decades.
World J Surg., Jul;35(7):1567-72 (2011)
Surgical resident involvement is safe for common elective general surgery procedures.
J. Am. Coll. Surg., Jul;213(1):19-26; discussion 26-8 (2011)
Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis.
J. Surg. Res., Jun;168(2):e173-80 (2011)
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
Melanoma Res., Jun;21(3):235-43 (2011)
Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis.
J Surg Oncol., Apr;103(5):390-4 (2011)
Tumor location predicts survival in cutaneous head and neck melanoma.
J. Surg. Res., May;167(2):192-8 (2011)